1. Home
  2. ESSA vs ZNTL Comparison

ESSA vs ZNTL Comparison

Compare ESSA & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESSA
  • ZNTL
  • Stock Information
  • Founded
  • ESSA 1916
  • ZNTL 2014
  • Country
  • ESSA United States
  • ZNTL United States
  • Employees
  • ESSA N/A
  • ZNTL N/A
  • Industry
  • ESSA Banks
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESSA Finance
  • ZNTL Health Care
  • Exchange
  • ESSA Nasdaq
  • ZNTL Nasdaq
  • Market Cap
  • ESSA 206.9M
  • ZNTL 227.0M
  • IPO Year
  • ESSA N/A
  • ZNTL 2020
  • Fundamental
  • Price
  • ESSA $19.50
  • ZNTL $3.00
  • Analyst Decision
  • ESSA
  • ZNTL Buy
  • Analyst Count
  • ESSA 0
  • ZNTL 8
  • Target Price
  • ESSA N/A
  • ZNTL $10.50
  • AVG Volume (30 Days)
  • ESSA 13.4K
  • ZNTL 1.1M
  • Earning Date
  • ESSA 01-22-2025
  • ZNTL 11-12-2024
  • Dividend Yield
  • ESSA 3.08%
  • ZNTL N/A
  • EPS Growth
  • ESSA N/A
  • ZNTL N/A
  • EPS
  • ESSA 1.78
  • ZNTL N/A
  • Revenue
  • ESSA $67,843,000.00
  • ZNTL $40,560,000.00
  • Revenue This Year
  • ESSA N/A
  • ZNTL N/A
  • Revenue Next Year
  • ESSA N/A
  • ZNTL N/A
  • P/E Ratio
  • ESSA $10.96
  • ZNTL N/A
  • Revenue Growth
  • ESSA N/A
  • ZNTL N/A
  • 52 Week Low
  • ESSA $15.29
  • ZNTL $2.66
  • 52 Week High
  • ESSA $21.50
  • ZNTL $18.07
  • Technical
  • Relative Strength Index (RSI)
  • ESSA 43.34
  • ZNTL 41.60
  • Support Level
  • ESSA $19.58
  • ZNTL $2.80
  • Resistance Level
  • ESSA $20.30
  • ZNTL $4.00
  • Average True Range (ATR)
  • ESSA 0.54
  • ZNTL 0.27
  • MACD
  • ESSA -0.15
  • ZNTL -0.06
  • Stochastic Oscillator
  • ESSA 23.53
  • ZNTL 17.01

About ESSA ESSA Bancorp Inc.

ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Share on Social Networks: